For the second meeting, we have invited Thomas J. Kipps, M.D., Ph.D., Director of the Center for Novel Therapeutics as a guest speaker. We look forward for your participation.
Date and Brief Agenda
Nov 20, 2020 (Fri) (Kyoto):
– 9：00～9：45am “Targeting Cancer Stemness”
– 9：45～10：00am Q&A
*Nov 19, 2020 (Thu) (San Diego):
– 4：00～4：45pm “Targeting Cancer Stemness”
– 4：45～5：00pm Q&A
Guest Speaker
Thomas. J Kipps Director, Center for Novel Therapeutics
／Distinguished Professor of Medicine, Moores Cancer Center, University of California, San Diego
Thomas J. Kipps earned his M.D. and Ph.D. degrees from Harvard Medical School in 1979. He was appointed associate professor at UC San Diego in 1990 and promoted to the rank of professor in 1994. He is internationally recognized for his contributions to the understanding of the immunobiology, cell biology and molecular genetics of human B-cell malignancies, with emphasis on Chronic Lymphocytic Leukemia (CLL). He conducted the first FDA-approved Phase I gene therapy trial for cancer in San Diego. He also discovered a new type of cell that protects leukemia cells, prompting him to name them “nurselike” cells (NLCs). Recently, Dr. Kipps has discovered that the antigen ROR1 is expressed on CLL. ROR1 is a type I membrane receptor tyrosine kinase-like surface protein. ROR1 was not expressed on normal, healthy adult tissues, but was found on the leukemia cells of virtually all cases of CLL and on the neoplastic cells of many patients with solid tumors. The monoclonal antibody targeted to ROR1 (Cirmtuzumab) is currently in a Phase1/2 clinical trial.
Facilitator
-Masatoshi Hagiwara, M.D., Ph.D., Professor of Graduate School of Medicine, Kyoto University/ Director of Kyoto University Research Center San Diego
-J. Silvio Gutkind, Ph.D., Distinguished Professor of Pharmacology and Associate Director of the Moores Cancer Center
Registration Link (Zoom Webinar)
https://uchealth.zoom.us/webinar/register/WN_2AbWwfqJS1uzn3hXoN1cNA
*Pre-registration is required.
Reference
Kyoto University Research Center San Diego (KURC- SD) HP:
https://www.kurcsd.com/
Contact Information
Kyoto University, Graduate School of Medicine, Research Promotion Office (Chiaki Murata)
E-mail: 060kensui@mail2.adm.kyoto-u.ac.jp
Co-sponsored by
Kyoto University Graduate School of Medicine
Kyoto University Research Center San Diego
Kyoto University Graduate Program for Medical Innovation
University of California, San Diego Moores Cancer Center
Center for Novel Therapeutics
